Literature DB >> 10568520

Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain.

T Sugino1, K Nozaki, Y Takagi, I Hattori, N Hashimoto, J Yodoi.   

Abstract

Thioredoxin (TRX) is a small, multifunctional protein with a redox-active site and multiple biological functions that include reducing activity for reactive oxygen intermediates. We assayed TRX by immunohistochemical methods in the rat brain after intraperitoneal injection of 3-nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase. Systemic administration of 3-NP produced lateral striatal, hippocampal CA1 and CA3 lesions in the present study. The immunoreactivity for TRX was enhanced in hippocampal CA3, dentate gyrus and lateral striatum, but not detected in hippocampal CA1 subfield after 3-NP intoxication. The data suggest that TRX may play an important role in the pathogenesis of 3-NP neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568520     DOI: 10.1016/s0304-3940(99)00763-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.

Authors:  Jai Malik; Maninder Karan; Rachna Dogra
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

2.  Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis.

Authors:  Aya M Mustafa; Mostafa A Rabie; Hala F Zaki; Aya M Shaheen
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

Review 3.  Thioredoxin system regulation in the central nervous system: experimental models and clinical evidence.

Authors:  Daniela Silva-Adaya; María E Gonsebatt; Jorge Guevara
Journal:  Oxid Med Cell Longev       Date:  2014-02-27       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.